The medical value of biomarkers in cardiovascular diseases management

cardiovascular diseases management event

Despite the treatments available for cardiovascular diseases, hospitalization and mortality rates remain high. 


How to make a difference?


Learn how innovative biomarkers can be key to optimize cardiovascular disease management and improve patient outcomes and quality of life1,2,3 by joining our scientific event "The medical value of biomarkers in cardiovascular disease management" on Wednesday, 23rd of October, 2019 from 6:00 to 10:00 PM at the Faculty Club in Leuven.


A request for accreditation has been submitted for this scientific event.

Date & Agenda

23rd of October, 2019, 18:00 to 22:00 


18:00 - 18:30: Welcome & Drink


18:30 - 18:45: Introduction by the Chairman

Prof Stefan Janssens, MD, PhD (UZ Leuven, Cardiovascular Diseases Department)


18:45 - 19:30:  "High-sensitive troponin T: challenges and opportunities"

Prof Pieter Vermeersch, MD, PhD - UZ Leuven, Laboratory Medicine


19:30 - 20:15: "The implementation of a heart failure care path in Leuven: the role of cardiac biomarkers" 

Dr Bert Vaes, MD, PhD - KU Leuven, Academische Centrum Huisartsgeneeskunde


20:15 - 21:00: "Novel biomarkers in acute and chronic HF. A call for action"

Prof Antoni Bayes-Génes, MD, PhD, FESC, FHFA - Hospital Universitari Germans Trias i Pujol, Spain


21:00 - 22:00: Network & Dine


Faculty Club is situated along the ring road of Leuven, just off the E40/E314 and has parking facilities for 250 cars – only a 15-minute drive from the airport by train or car – 20 minutes from Brussels.

Faculty Club Leuven

Groot Begijnhof 14

3000 Leuven, Belgium

Register now

Form Successfully Submitted!
Thank you for your submission!
I agree to receive marketing material from Roche and my preferences may be kept to ensure that Roche provides me with customized content specific to my wishes.
I am aware I can revoke given permissions at any time via the unsubscribe link in the footer of Roche emails. To protect your data we have stringent security guidelines in place for all our employees as well as external partners/suppliers who have access to the Roche worldwide customer database. For further details, please also see our

1. World Heart Failure Alliance. White Paper: Heart failure, preventing disease and death worldwide. Web:

2. Cowie, M.R. et al. (2013) Improving care for patients are acute heart failure. Retrieved from:

3. Krumholz HM, et al. (2009). Patterns of hospital performance in acute myocardial infarction and heart failure 30-day mortality and readmission. Circ Cardiovasc Qual Outcomes.;2(5):407-413